1992-2007年哈尔滨市南岗区乳腺癌发病率和死亡率分析

doi:10.3969/j.issn.1002-3070.2011.03.014

PRACTICAL ONCOLOGY JOURNAL ›› 2011, Vol. 25 ›› Issue (3): 257-260.doi: 10.3969/j.issn.1002-3070.2011.03.014

Previous Articles Next Articles

Received:2010-09-07 Online:2011-03-25 Published:2012-02-21

Abstract

CLC Number:

R737.9

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.3969/j.issn.1002-3070.2011.03.014

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2011/V25/I3/257

[1]	LI Xudong, LIU Tong. The single cell transcriptome sequencing reveals the role and prognostic value of PCLAF and ERO1A in the progression of breast cancer [J]. Journal of Practical Oncology, 2025, 39(5): 418-427.
[2]	LYU Rui, ZHEN Linlin. Research progress on bone microenvironment-mediated drug resistance in breast cancer bone metastasis [J]. Journal of Practical Oncology, 2025, 39(5): 450-456.
[3]	WANG Rui, MA Deyuan, JIA Wangqiang, GUAN Quanlin. Application and progress of nano-medicine mediated cuproptosis in the breast cancer treatment [J]. Journal of Practical Oncology, 2025, 39(2): 144-150.
[4]	WANG Shuai, LI Qiqing, LI Rui, XU Tiefeng. Advances in the application of nanoparticles in the diagnosis and treatment of breast cancer [J]. Journal of Practical Oncology, 2025, 39(2): 151-156.
[5]	WANG Ru, ZHANG Hongxia. Research progress on the application of magnetic resonance imaging technology in predicting lymphatic vascular invasion in breast cancer [J]. Journal of Practical Oncology, 2025, 39(2): 162-168.
[6]	GU Wen, ZHOU Lan, JIA Yanni, HUANG Weidong. Validation of measurement attributes for QLU-C10D scale in breast cancer patients [J]. Journal of Practical Oncology, 2025, 39(1): 49-55.
[7]	SHI Changyong, ZHOU Zizhen, ZHOU Guanglin, XIONG Yimin. The values of DCE-MRI quantitative parameters combined with NCAPH in the diagnosis of early breast cancer [J]. Journal of Practical Oncology, 2025, 39(1): 56-60.
[8]	PANG Wanying, AN Jing, LIU Zhaoliang. The role and mechanism of TRIM24 in endocrine therapy resistance of breast cancer [J]. Journal of Practical Oncology, 2024, 38(6): 402-409.
[9]	ZHANG Yuqing, JING Jing, LIU Zhaoliang, AN Jing, AN Weiwei. The alternative splicing event of MZB1 is a potential biomarker of drug resistance in endocrine therapy of breast cancer [J]. Journal of Practical Oncology, 2024, 38(5): 313-322.
[10]	YANG Minye, XIAN Tongcheng, LIU Jingjian, BIE Jun, WANG Jie, LUO Yi. The expression of IL-23 in breast cancer tissues and its correlation with clinicopathological characteristics [J]. Journal of Practical Oncology, 2024, 38(5): 323-329.
[11]	LIU Dong, ZHANG Taijuan, DANG Jifeng. The research progress of inflammatory reaction driving breast cancer metastasis [J]. Journal of Practical Oncology, 2024, 38(5): 336-341.
[12]	LI Qianni, XU Lingyan, LI Jian, YAO Xuepei, LIU Meina. Trend analysis of a longitudinal evaluation for multidimensional treatment quality of breast cancer [J]. Journal of Practical Oncology, 2024, 38(4): 213-220.
[13]	SHAO Yuming, ZHU Kunbing, ZHANG Jie. Research progress of SP/NK-1R system in breast cancer [J]. Journal of Practical Oncology, 2024, 38(4): 268-272.
[14]	YIN Haiyan, CHUN Zhiming, MA Qiaojun, CHENG Han, DING Gaoheng, LIU Yuqin, ZHANG Haiyan. Epidemic characteristics of female breast cancer in cancer registration areas of Gansu province in 2019 and trend analysis from 2010 to 2019 [J]. Journal of Practical Oncology, 2024, 38(3): 141-148.
[15]	LI Jiahao, BAI Jiahe, LAN Jie, LI Haixia, ZHANG Yan, SUN Jianghong. The classification performance of MMV-Net model for benign and malignant masses on X-ray mammography using deep learning [J]. Journal of Practical Oncology, 2024, 38(3): 179-183.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments